Back to trial

Eligibility Pre-Screening

Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 60%

1.Have you been diagnosed with metastatic uveal (eye) melanoma that has spread mainly to the liver, confirmed by pathology?